4 results on '"Cefixime therapeutic use"'
Search Results
2. [Whipple's disease].
- Author
-
Puéchal X
- Subjects
- Administration, Oral, Adolescent, Adult, Age Factors, Aged, Anti-Bacterial Agents administration & dosage, Anti-Bacterial Agents therapeutic use, Anti-Infective Agents administration & dosage, Anti-Infective Agents therapeutic use, Antibodies, Bacterial analysis, Cefixime administration & dosage, Cefixime therapeutic use, Female, Humans, Immunohistochemistry, Magnetic Resonance Imaging, Male, Middle Aged, Polymerase Chain Reaction, Recurrence, Sex Factors, Sulfamethoxazole administration & dosage, Sulfamethoxazole therapeutic use, Time Factors, Trimethoprim administration & dosage, Trimethoprim therapeutic use, Tropheryma genetics, Tropheryma isolation & purification, Whipple Disease diagnosis, Whipple Disease drug therapy, Whipple Disease epidemiology, Whipple Disease immunology, Whipple Disease microbiology
- Abstract
Whipple's disease is a chronic, multisystemic, curable, bacterial infection that usually affects middle-aged men. It has a wide range of clinical manifestations. In the historical presentation, weight loss and diarrhoea are the most common symptoms and are preceded in three-quarters of cases by arthritis for a mean of six years. Long-term, unexplained, seronegative oligoarthritis or polyarthritis of large joints with a palindromic or relapsing course is typical. In most patients, periodic acid-Schiff staining of proximal small bowel biopsy specimens reveals inclusions within the macrophages, corresponding to bacterial structures. However, patients may have no gastrointestinal symptoms, negative jejunum biopsy results and even negative PCR tests. Even in the absence of gastrointestinal symptoms, Whipple's disease should be considered in case of negative blood culture endocarditis, unexplained central neurological manifestations or unexplained arthritis. Identification of the causative bacterium, Tropheryma whipplei, has led to the development of PCR as a diagnostic tool, particularly useful in patients in the early stages of the disease or with atypical disease. The recent cultivation of T. whipplei and the complete sequencing of its genome should improve our understanding and treatment of the disease. The future development of an assay for detection of specific antibodies in the serum and generalization of the immunohistochemical detection of antigenic bacterial structures may allow earlier diagnosis, thereby preventing the development of the severe late systemic and sometimes fatal forms of the disease.
- Published
- 2009
- Full Text
- View/download PDF
3. [Management of acute pyelonephritis in patients older than 3 months: survey conducted in 39 paediatric emergency departments of the Ile de France Region in 2004].
- Author
-
de La Vaissière B, Castello B, Quinet B, Cohen R, and Grimprel E
- Subjects
- Acute Disease, Administration, Oral, Adolescent, Age Factors, Anti-Bacterial Agents administration & dosage, Anti-Bacterial Agents therapeutic use, Cefaclor administration & dosage, Cefaclor therapeutic use, Cefixime administration & dosage, Cefixime therapeutic use, Ceftriaxone therapeutic use, Child, Child, Preschool, Data Collection, Drug Therapy, Combination, Emergency Service, Hospital, Follow-Up Studies, France, Humans, Infant, Infusions, Parenteral, Injections, Intravenous, Intensive Care Units, Pediatric, Outpatients, Pyelonephritis complications, Pyelonephritis diagnosis, Pyelonephritis diagnostic imaging, Pyelonephritis drug therapy, Surveys and Questionnaires, Time Factors, Trimethoprim, Sulfamethoxazole Drug Combination administration & dosage, Trimethoprim, Sulfamethoxazole Drug Combination therapeutic use, Ultrasonography, Urethra diagnostic imaging, Urinary Bladder diagnostic imaging, Urography, Pyelonephritis therapy
- Abstract
Objectives: To describe the different modalities of ambulatory management of acute pyelonephritis in patients older than 3 months of age in paediatric emergency units of the Ile de France region in 2004., Methods: Between October 2003 and April 2004, referents of 39 paediatric emergency units of the Ile de France region were questioned through a written questionnaire concerning the management of acute pyelonephritis: in or outpatient modalities, antibiotic regimen (molecule and route of administration), investigations and follow-up., Results: Thirty-one questionnaires (79.5%) were returned and analysed. A written protocol was available in 60% of the units. Outpatient management was performed in 24/31 centres. Young age, poor clinical tolerance, urological abnormalities and social difficulties were the major contra-indications for such management. Ultrasonic echography at diagnosis (within 24 h) was performed in 50% of the units. Antibiotics were started using IV route in 18/24 units (75%) and ceftriaxone and aminoside were respectively prescribed in 100% and 29.4% of the units for a duration of 1 to 5 days before switching to the oral route. Antibiotherapy was started orally in 6 units and cefixime was chosen by 5 of them. Follow-up consultations were scheduled in 100% of the units but with various delay after initiation of the treatment. The total duration of treatment was mostly 10 days and oral prophylactic antibiotherapy was prescribed by 10/24 centres after completion of the treatment. Cystoureterography was systematically realized by 83.3% of the units., Conclusions: Despite important differences in the management of acute pyelonephritis in Ile-de-France, a majority of the units follows similar therapeutic modalities. In the absence of consensus, new recommendations are necessary concerning the management of pyelonephritis in infants and children in France.
- Published
- 2006
- Full Text
- View/download PDF
4. [Infectious complications of mandibular osteotomy].
- Author
-
Cheynet F, Chossegros C, Richard O, Ferrara JJ, and Blanc JL
- Subjects
- Adolescent, Adult, Antibiotic Prophylaxis, Bone Plates adverse effects, Cefamandole therapeutic use, Cefixime therapeutic use, Cephalosporins therapeutic use, Cutaneous Fistula etiology, Female, Follow-Up Studies, Hematoma etiology, Humans, Lymphadenitis etiology, Male, Middle Aged, Oral Hygiene, Osteitis etiology, Periodontal Diseases complications, Retrospective Studies, Risk Factors, Smoking adverse effects, Surgical Wound Infection prevention & control, Time Factors, Mandible surgery, Osteotomy adverse effects, Surgical Wound Infection etiology
- Abstract
Background: Infection is a rare complication after orthognathic surgery. A rate of 1% to 15% has been reported in the literature. We reviewed our experience., Material and Methods: We reviewed retrospectively 60 mandibular osteotomies performed between 1998 and 1999. There were 41 women and 19 men, mean age 24 years. All were given antibiotic therapy using cefamandol 1500 mg preoperatively then 750 mg every 6 hours peroperatively and cefixime 400 mg/d postoperatively for 7 days. Patients were followed for at least 6 months after surgery., Results: There were 10 infections (16% of the cases) involving a hematoma in 2 cases, adenitis in 1, osteitis on a cortical fragment in 2 and osteitis on implanted material in 5., Discussion: We defined infection following orthognathic surgery as a collection or purulent fistula with either a high polynuclear count in the discharge fluid or a positive culture. Both soft tissue (for example infection of a perimandibular hematoma) or bone infections were equally considered. We found two types of risk factors: patient-related or procedure-related. Patient-related factors included smoking, paradontal status, and dental hygiene. The main procedure-related factor was duration of surgery. Measures of prevention include extraction of the wisdom teeth, interruption of smoking, preoperative scaling and careful dental care, rigorous operative technique, antibiotic therapy.
- Published
- 2001
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.